Godavari Drugs (BOM:530317) COGS-to-Revenue : 0.80 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs COGS-to-Revenue?

Godavari Drugs's Cost of Goods Sold for the three months ended in Dec. 2023 was ₹343 Mil. Its Revenue for the three months ended in Dec. 2023 was ₹431 Mil.

Godavari Drugs's COGS to Revenue for the three months ended in Dec. 2023 was 0.80.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Godavari Drugs's Gross Margin % for the three months ended in Dec. 2023 was 20.38%.

Godavari Drugs COGS-to-Revenue Historical Data

The historical data trend for Godavari Drugs's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs COGS-to-Revenue Chart

Godavari Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

COGS-to-Revenue

Get a 7-Day Free Trial

0.78

0.80

0.79

0.81

0.80

Godavari Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.82	0.77	0.79	0.78	0.80

Godavari Drugs COGS-to-Revenue Calculation

Godavari Drugs's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1280.577	/	1596.248
	=	0.80

Godavari Drugs's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	343.258	/	431.105
	=	0.80

Godavari Drugs (BOM:530317) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Godavari Drugs's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	343.258 / 431.105
	=	20.38 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Godavari Drugs COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Godavari Drugs (BOM:530317) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003

Website

https://www.godavaridrugs.com

Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines